ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, SEMA6A, HSPG2, DCN, COL4A2, HGS, CX3CR1, THBS2, THBS1, E2F2, SEMA4A, TGFB2, STAT1, PLK2, TIE1, KLF4, SULF1, PML, CXCL10, TEK, PF4]
GO:0060760;positive regulation of response to cytokine stimulus;5.0;0.6997970393407541;0.6401395315312973;8.438940185618286;40.71357550929856;5.825829909099042;0.0013626467324571242;0.5881742243410422;[TXK, GFI1, TAF9, TREM2, IFIH1, CD74, MED1, EDN1, IL1R1, DDX58, RIPK2, PARP9, MMP12, IRF7, TLR4, TLR2]
GO:0035563;positive regulation of chromatin binding;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;31.32148238131123;7.292166977892469;0.0010483018277984315;0.6631627702307852;[CDT1, GMNN, PARP9]
GO:0016925;protein sumoylation;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;311.84626772129184;6.250713103064308;0.010437213937211602;0.7159023839588838;[IFIH1, RANBP2, EGR2, CBX4, BCL11A]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, ZFYVE16, GATA3, LYN, ABCA1, COL1A1, SRP9, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, SEC63, GOLPH3L, HNF1B, ACTN4, KIF20A, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, ZFAND6, CARD11, ECT2, NUP155, NASP, PLEK, NUP62, YWHAH, NUP133, TBC1D8, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, AP1S2, HOMER3, CUBN, PRKCB, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, EXOC1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, PLEKHF2, TLK1, NLGN1, UNC93B1, VPS4B, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, F2RL1, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, LTBP2, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, HDAC2, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, IL18, OSM, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1]
GO:0045648;positive regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;358.80145150428314;6.409777797693995;0.012008761681506467;0.7027963346592216;[MED1, STAT1, HMGB2, ISG15, INHBA, MAPK14, GATA1, ETS1, TAL1, INPP5D, NCKAP1L]
GO:0060368;regulation of Fc receptor mediated stimulatory signaling pathway;6.0;0.8436909121759173;0.7449657686781032;9.446202695698167;67.47621599979578;7.9853141584524145;0.0022583682248613433;0.7314896500084853;[LYN, PLSCR1, CSK]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[LYN, STAT1, PRL, GHR, SOCS2, GH1, STAT4, CCL2, JAK3, CCR2]
GO:0032727;positive regulation of interferon-alpha production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.7325511899570465;0.0028249751562838235;0.6952223462072524;[CHUK, DDX58, RIPK2, STAT1, HSPD1, MMP12, IFIH1, IRF7, TLR8, TLR7, TLR4]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, ITGB5, HLA-B, TAP1, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, CD36, FCGR1A, FCGR1B]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[HMGB2, IFIH1, DDX58, RIPK2, IRF7, TLR8, TLR7, TLR4, TLR2]
GO:0019885;antigen processing and presentation of endogenous peptide antigen via MHC class I;5.0;0.8436909121759173;0.712086467948879;9.271849308553389;32.556158890958;7.8311634786251565;0.0010896253394395913;0.6907270763441554;[TAP1]
GO:2000110;negative regulation of macrophage apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;256.26138950429646;7.9853141584524145;0.008576838086431384;0.8046099625986299;[GHSR, CCL5, IRF7, NOD2, CCR5]
GO:2000373;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;7.0;1.0;0.8509193652572005;9.628524252492122;112.16415423977526;7.9853141584524145;0.0037540333012201187;0.7592887026755414;[PLSCR1, UHRF1]
GO:0045655;regulation of monocyte differentiation;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;139.67875005531917;6.8867018697843045;0.0046749220616377945;0.7271862538851576;[CD74, CD4, JUN, CDK6, INPP5D, IRF7, ACIN1, HOXA7]
GO:0003340;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;8.0;1.0;0.875;9.628524252492122;683.3567818519086;8.67846133901236;0.022871336507407674;0.8188169164668168;[STAT1]
GO:1904469;positive regulation of tumor necrosis factor secretion;10.0;1.0;0.9152410118609203;9.628524252492122;775.9675723657698;7.292166977892469;0.025970936321606315;0.7881627702307852;[IFIH1, ORM1, FZD5, DDX58, LRRK2, HAVCR2]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, CDCA5, RAD21, HMOX1, SFN, BARD1, LYN, MCTS1, PLK2, PLK1, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, FANCI, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK1, BCL2, BCL2L1, MCM7, EXO1, TLK1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, UHRF1, CDC45, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, DONSON, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, ESCO2, MIF, EPHA2, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, SP100, PCNA, RAD54B, RAD54L, GINS2, RPA1, MLH1, RPA3, NEDD4, TRIP13, DCLRE1A, LIG1, FANCD2, PSMD14, CCNB1, HMGA1, ISG15, JMY, TOPBP1, H2AFX, IRF7, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0061326;renal tubule development;5.0;0.6664901433067099;0.6234860835142753;8.32924126836186;33.009488292418915;6.8867018697843045;0.0011047978665365144;0.6424272657460779;[JAG1, STAT1, HNF1B, DLL1, PAX2, ACAT1]
GO:0071360;cellular response to exogenous dsRNA;7.0;1.0;0.8509193652572005;9.628524252492122;172.52541059605554;7.069023426578259;0.005774270229860956;0.7124295520356204;[COLEC12, IFIH1, DDX58, CAV1, IFIT1]
GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.069023426578259;0.0049295844405465;0.7124295520356204;[CCL20, STAT1, LRRK2, NOD2, FCER2, CCL2, TLR4, TLR2, MAP2K6]
GO:0046597;negative regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.95196338807416;6.832634648514029;0.002843265762795464;0.7244212536750128;[FCN1, IFITM1, GSN, IFNA2, TRIM25, PTX3, TRIM10]
GO:0051097;negative regulation of helicase activity;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;49.94359093049245;8.390779266560578;0.0016715670421299067;0.7522251544931926;[IFIT1, SIRT1, MCM2]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, CFP, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QB, C1QA, PTGS2, NT5E, IGKC, CCL18, IL33, CCL23, NR1H4, OSM, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, GHSR, ADCYAP1, FANCD2, ADAM8, S100A9, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, GPX1, TNFRSF1B, LTA, XCL1, BIRC2, BIRC3, C1S, C1R, NLRC3, NOD2, USP18, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, TEK, FCGR2B]
GO:0035549;positive regulation of interferon-beta secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.0580298608876;8.390779266560578;0.025907025652444588;0.8443458537639685;[IFIH1, DDX58]
GO:0033003;regulation of mast cell activation;6.0;0.7369933605727446;0.6916169928765168;9.176539128749065;27.112248267214866;6.113511981550823;9.074225500643868E-4;0.635765599634035;[STXBP2, CNR1, RAC2, HMOX1, IL13RA2, LYN, FCER1G, SYK, GAB2, FGR, PLSCR1, NR4A3, FES]
GO:0050689;negative regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;351.96651544657516;8.16763571524637;0.011780002522698075;0.7926932703116032;[IFIT1]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, ICAM1, LGALS1, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, STAT1, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, PDE4D, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, HDAC2, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5, RPS6KB1]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, IRF7, TLR6, CD14, TLR4]
GO:0050688;regulation of defense response to virus;6.0;0.7508913569872202;0.6985659910837546;9.193206181234276;71.29061093166123;5.557565922504363;0.002386032590498313;0.6073344923202633;[TNFAIP3, IFIT1, HERC5, DHX58, DDX58, PARP9, MMP12, IL23A, IL1B, BIRC2, BIRC3, HTRA1, DDX60, IL12RB1, STAT1, LILRB1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0043367;CD4-positive, alpha-beta T cell differentiation;8.0;0.7763722522362496;0.7631861261181248;9.310070521373587;117.17127606415333;6.641579411751319;0.003921617162564973;0.7146506799819907;[SEMA4A, RSAD2, LEF1, RORA, GATA3, RELB, FUT7, BCL3, IL18R1, NKX2-3]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[TNFAIP3, RORA, NLRC3, PYCARD, STAT1, NR1H4, RHOH, SIRT1, NLRP12, TNIP3, CCDC22, ZMYND11, NFKBID]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CEBPA, CEBPB, IFITM1, CYR61, IL6R, CTHRC1, MEF2C, JAG1, RUNX2, IL6, BMP2, SFRP2, FAM20C, LTF]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0006302;double-strand break repair;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;183.0506323445446;4.689477292448085;0.006126539929698291;0.6148200868187911;[DCLRE1A, FEN1, BRCA1, BRCA2, H2AFX, ESCO2, PARP9, RAD51C, MSH2, BLM, PSMD14, CDCA5, RAD54B, CDC45, RAD21, RBBP8, RAD54L, BARD1, GINS2, RPA1, MLH1, POLA1, RAD50, RAD51, RPA3, TRIP13]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, STAT1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0006659;phosphatidylserine biosynthetic process;8.0;1.0;0.875;9.628524252492122;760.197002493669;8.390779266560578;0.025443109540578525;0.8041048419030481;[PLSCR1]
GO:0019060;intracellular transport of viral protein in host cell;11.0;1.0;0.9324289523296623;9.628524252492122;185.43516432665677;9.083926447120524;0.006206348069200128;0.8969813732811862;[IFIT1]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[DDX58, F2R, TWIST1, PYCARD, IFIH1, IL1B, TLR8, F2RL1, IL17A]
GO:1990668;vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;65.8060249050737;7.9853141584524145;0.0022024684319953925;0.7592887026755414;[TAP1]
GO:0070102;interleukin-6-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.138016298065211;0.00101047745553359;0.7159578506919597;[STAT1, IL6, IL6R]
GO:0070106;interleukin-27-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[STAT1, EBI3]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC2, BIRC3, USP18, FAM105A, USP1, IL33, USP9Y, PSMC6, TNIP3, PSMC2, EIF3F]
GO:0034165;positive regulation of toll-like receptor 9 signaling pathway;9.0;0.9326813400603323;0.8625812952104552;9.590783924509275;505.2767808384828;9.083926447120524;0.01691115913508416;0.8607930461318132;[RSAD2]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[HERC5, SKP2, FBXW2, CDC34, BARD1, HACE1, UBE2C, MARCH1, BCL2, TNFAIP3, BRCA1, UBE2Q2, RNF144B, DTL, BIRC2, RNF6, ZNRF1, RNF24, NEDD4]
GO:0032020;ISG15-protein conjugation;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;7.9853141584524145;0.005059013543235805;0.7592887026755414;[HERC5, ISG15]
GO:1902741;positive regulation of interferon-alpha secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.0580298608876;7.8311634786251565;0.025907025652444588;0.8157270763441555;[MMP12, IFIH1, CHUK, DDX58]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[DDX58, STAT1, LILRB1, PARP9, IL23A, IL12RB1]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0001937;negative regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.36028873802138;6.193554689224359;0.002923870244906099;0.6676580400938822;[MEF2C, SPARC, CAV2, STAT1, CAV1, PRL, NR2F2, SULF1, TNF, THBS1, CCL2]
GO:0034157;positive regulation of toll-like receptor 7 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;505.2767808384828;9.083926447120524;0.01691115913508416;0.8607930461318132;[RSAD2]
GO:0038114;interleukin-21-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.697632086000634;0.00101047745553359;0.7445766281117727;[STAT1, STAT4, IL21R, IL2RG, JAK3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, TRIP13, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0009597;detection of virus;6.0;1.0;0.8231203125901445;9.628524252492122;28.654098265158677;8.16763571524637;9.59026881920657E-4;0.7408135829017477;[IFIH1, DDX58, SERINC5]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, ARRB2, IFIT1, IFIT2, RUVBL2, STMN1, AKT1, IL10, ITGA4, PRKCD, AES, SLPI, LEF1, ADRB2, AURKB, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA, DAB2, ID1, CAMK1]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM1, PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, STAT1, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0072308;negative regulation of metanephric nephron tubule epithelial cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;661.6957578520695;9.777073627680469;0.022146361527789024;0.896240625180289;[STAT1]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[IL6, RSAD2, NLRP3, XCL1, GATA3, PRKCZ]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, MED1, PRKCD, PARP9, IFNG, HCLS1, PTGS2, FYN, CCT8, CCT7, ECT2, CCT5, CCT4, TGFB1, JUP, PLK1, LIF, MAPK14, CCT6A, CDK1]
GO:0032480;negative regulation of type I interferon production;6.0;0.7980440201809971;0.722142322680643;9.186691500213083;65.25422870398782;6.015873511986907;0.002184000309729388;0.6307723637598831;[TNFAIP3, NLRC3, RELB, PYCARD, IFIH1, HERC5, DHX58, TRIM25, HAVCR2, IL10, DDX58, LILRB1, ISG15]
GO:0002053;positive regulation of mesenchymal cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;64.15119587261817;6.444869117505266;0.002147082793528545;0.6527112189764278;[PRRX1, STAT1, IHH, PDGFA]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[PLXND1, STAT1, MAML3]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF13B, TNF, TNFSF13B, PYCARD, TNFSF11, CHUK, TNFRSF1B, LTA, LTB, BIRC2, BIRC3, TNFRSF11A, TNFRSF17, TNFSF14, STAT1, TNFSF12, TNFSF13, TNFRSF10C, TNFRSF10B, NFKBIA, CD40LG, CD27, LTBR]
GO:0072136;metanephric mesenchymal cell proliferation involved in metanephros development;4.0;1.0;0.75;9.628524252492122;28.01271973260729;8.67846133901236;9.375605196393662E-4;0.6938169164668168;[STAT1]
GO:0010742;macrophage derived foam cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.8311634786251565;7.282666309192915E-4;0.6907270763441554;[TGFB1, STAT1]
GO:0070757;interleukin-35-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[STAT1, EBI3, STAT4, IL12RB2]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0060340;positive regulation of type I interferon-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;527.9279232538245;7.379178354882098;0.017669272487020958;0.7523715242355574;[MMP12, IRF7]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUNB, JUN, IGFBP5, DUSP1, STAT1, FOS, NME1, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, FOSB, TEK, SLC26A3, CFTR, BIRC2]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[CDKN1A, CCNT2, CCNH, TNFAIP3, CCNC, HERC5, HHEX, AKT1, MEN1, MYOCD, CDC25A, CCNA2, PSRC1, CCNE2, CCNE1, CKS2, CEBPA, BLM, PKMYT1, CCNB2, CCNB1, SFN, CDKN2C, PLK1, GTF2H1, CDC6, NR2F2, CDK6]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[CYFIP1, AKT1, GHSR, CEACAM1, RAB31, FOXO1, PAK1, STAT1, SORBS1, RPS6KB1]
GO:0072162;metanephric mesenchymal cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;73.29838936289404;8.16763571524637;0.0024532311277084;0.7686126355688037;[STAT1, PAX2]
GO:0045351;type I interferon biosynthetic process;7.0;0.8933024483968273;0.7975705894556142;9.485423408851448;91.32533419757507;9.083926447120524;0.003056576748128122;0.8154717862087246;[IRF7]
GO:0017121;phospholipid scrambling;5.0;0.7980440201809971;0.6892630219514189;9.117698628726131;49.436230899548704;7.212124270218933;0.0016545861584886027;0.659069382437994;[PLSCR1]
GO:0034127;regulation of MyD88-independent toll-like receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;90.3094294018114;7.697632086000634;0.0030225753288688696;0.7686572628545723;[IRF7, LY96, CD14, TLR4]
GO:0071357;cellular response to type I interferon;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;9.777073627680469;0.0027327542132076126;0.8231203125901445;[IFIT1]
GO:0034124;regulation of MyD88-dependent toll-like receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;90.3094294018114;8.390779266560578;0.0030225753288688696;0.8041048419030481;[IRF7]
GO:0045070;positive regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.31211810933421;6.221725566191056;0.0028553198171978322;0.6931793347948383;[TOP2A, ADARB1, IFIT1, CCL5, CD28]
GO:0002819;regulation of adaptive immune response;5.0;0.5153277057409312;0.5479048647313859;7.277148995328644;25.624977988756285;4.77312732173501;8.576449523007288E-4;0.5343389650675688;[TFRC, CD80, TNF, PYCARD, IL6R, MEF2C, RSAD2, SLC11A1, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, MSH6, MSH2, IL23A, BTK, PRKCQ, CD274, CD1E, GATA3, CD1D, CD1C, CD1B, PRKCZ, SAMSN1, CD1A, C3, NLRP3, TGFB1, FZD5, TNFSF13, IL6, PTPRC, BCL6, CD28, IL7R, NFKBID, CD40, IFNA2, TNFAIP3, TNFSF13B, DUSP10, JAK3, CCR2, HAVCR2, IL10, CR1, ANXA1, FCER1G, ARG1, RIPK2, IL18, SIRT1, FCER2, CEACAM1, IL1B, LTA, IRF7, XCL1, CD48, UNG, HSPD1, HLX, TBX21, CCL19, IL12RB1, IL33, LILRB1, MLH1, CD4, PTPN6, PKN1, CLC, FCGR2B]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[IFITM1, IFIT1, TNF, OASL, CCL5, RSAD2, EIF2AK2, ISG15, PLSCR1, SLPI, OAS1, OAS3, APOBEC3A, LTF]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, SAMSN1, C2, C3, KLRK1, C7, PLCG2, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, DUSP3, ARG1, IFNGR1, RIPK2, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, STAT1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, SIGLEC7, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, CLEC4A, ADCYAP1, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ARRB2, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, GPX1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, PIK3C3, BIRC2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, IFITM1, GFI1, ICAM2, ICAM3, ICAM1, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, CD48, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA1, LILRA2, RELB, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, LILRB4, CD40LG, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, LPXN, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, USP18, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0035458;cellular response to interferon-beta;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.004484905440688;0.0027327542132076126;0.6813299963962409;[CDC34, STAT1]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, ICAM1, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, IRF8, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, STAT1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0006471;protein ADP-ribosylation;7.0;0.7980440201809971;0.7499413753476991;9.245532000236016;151.15475272427284;6.641579411751319;0.005059013543235805;0.6905700452391912;[PARP9]
GO:0050709;negative regulation of protein secretion;8.0;0.6493065804076676;0.6996532902038338;8.749274792298316;381.9718045319581;5.058574756385375;0.01278425254537885;0.6336957482893315;[IFNA2, PTPN22, LRRC32, TNF, FAM3D, CD34, IL10, GHSR, ANXA1, RSAD2, IL1R2, F2R, BANK1, IL1B, TLR8, TLR6, NLRP3, DRD4, IL33, FN1, NR1H4, LILRB1, PML, NLRP12, FKBP1B, F2RL1, FCGR2B, LGR4]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, RAD21, PRDM16, NKX2-3, NFE2, SNAI2, BTG2, TGFB1I1, ZNF367, BRD2, PAWR, PAX5, PAX2, AES, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, LMO2, COL4A2, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:0039530;MDA-5 signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;557.6110095859297;8.67846133901236;0.018662738673513177;0.9063718812344532;[IFIH1, IRF7]
GO:1900245;positive regulation of MDA-5 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;756.7335043639653;8.390779266560578;0.02532718937512329;0.8253454670833372;[DHX58, DDX60]
GO:0060338;regulation of type I interferon-mediated signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;103.51609522721039;6.481236761676141;0.003464590548817385;0.6823701146576509;[USP18, MMP12, IRF7, PTPN6]
GO:1900246;positive regulation of RIG-I signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;756.7335043639653;7.8311634786251565;0.02532718937512329;0.7967266896635242;[DHX58, DDX60]
GO:0046725;negative regulation by virus of viral protein levels in host cell;7.0;1.0;0.8509193652572005;9.628524252492122;75.22412676741801;9.777073627680469;0.0025176838255866725;0.8509193652572005;[STAT1]
GO:0060334;regulation of interferon-gamma-mediated signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;117.87544056254812;6.558197802812269;0.003945184914619341;0.7103865406232063;[MED1, ARG1, IFNGR1, STAT1, NR1H2, IFNGR2, TXK, PARP9, IFNG]
GO:0046967;cytosol to ER transport;5.0;1.0;0.7902410118609202;9.628524252492122;33.20429938101479;9.083926447120524;0.0011113180183532213;0.7547934328124444;[TAP1]
GO:0060335;positive regulation of interferon-gamma-mediated signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;643.9725541340745;7.9853141584524145;0.021553181849195524;0.8046099625986299;[MED1, TXK, PARP9]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNA5, IFNA4, IFNA7, SP100, IFITM1, IFNA2, IFI6, SAMHD1, IFIT1, IFNA8, IFIT3, IFIT2, OASL, IFNA21, EGR1, IFNA14, RSAD2, IFNA16, STAT1, MX2, HLA-B, HLA-C, ISG15, HLA-A, HLA-F, HLA-G, HLA-E, IFI27, OAS1, OAS3, IRF7, IRF8, MYD88, IFNA10]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[, CDC20, PSMD3, TRIM25, SKP2, CDC34, HACE1, PLK1, TGFB1I1, SIRT1, PSMA5, PSMA6, RNF144B, PSMA3, PSMA4, PSMA2, PCNP, USP1, RANBP2, RANBP1, USP9Y, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, RNF43, PSMD14, CUL5, UBR1, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, DTL, BIRC2, UHRF1, VPS4B, RNF6, USP18, AURKB, ZNRF1, TBX21, RNF24, PML]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[FCN1, CLEC10A, ICAM2, ICAM3, PYCARD, IL18RAP, DHX58, PRKACB, MED1, LAG3, RSAD2, PRKCE, CD180, PRKCD, MUC3B, EREG, HLA-E, CLEC4A, CLEC4D, BTK, ADAM8, CLEC4E, S100A9, S100A8, CARD11, TXK, LY96, CD1D, DDX60, RASGRP1, KLRK1, CLEC7A, PLCG2, S100A14, CD14, MAP2K6, LYN, CAV1, SH2D1A, CRTAM, NFKB1, NFKBIA, MARCO, MYD88, ITGAM, ITGB2, HMGB2, TNFAIP3, PTPN22, CTSS, IFIH1, MUC13, FFAR2, MUC15, CD36, HAVCR2, FCER1G, CHUK, SYK, DDX58, RIPK2, MMP2, IRAK3, PARP9, VAV1, MMP12, TLR1, HCK, PLSCR1, IRF7, TLR8, TLR10, TLR7, PIK3C3, TLR6, TLR5, TLR4, LTF, TLR2, COLEC12, UNC93B1, NLRC4, NOD2, LILRA2, HSPD1, RELB, PAK1, NRAS, CCL5, FYN, CARD9, NR1H4, TNIP3, F2RL1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0034356;NAD biosynthesis via nicotinamide riboside salvage pathway;12.0;1.0;0.9481203125901445;9.628524252492122;2003.6404315682985;7.069023426578259;0.06706004208527355;0.8096304993685645;[PTGS2, PARP9]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL2, XCL1, IRF8, TLR4, TLR2, CCL13, STXBP2, AIF1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, STAT1, RPS6KB1, ZYX]
GO:2001034;positive regulation of double-strand break repair via nonhomologous end joining;10.0;1.0;0.9152410118609203;9.628524252492122;720.4197407163671;8.16763571524637;0.024111800386103676;0.8329342821725234;[PARP9]
